Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | SRPT | AMGN | GILD | VRTX | REGN |
| Company | Sarepta Therapeutics | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 126.07 | 333.93 | 83.37 | 483.78 | 1,151.32 |
| High | 128.08 | 339.00 | 84.52 | 483.78 | 1,156.40 |
| Low | 123.61 | 331.00 | 82.76 | 473.75 | 1,137.64 |
| Last | 125.01 | 332.92 | 83.89 | 474.16 | 1,138.81 |
| Change | -0.68 | +0.12 | +0.84 | -7.10 | -7.94 |
| % Change | -0.54% | +0.04% | +1.01% | -1.48% | -0.69% |
| Volume | 624,800 | 1,366,500 | 9,198,899 | 868,100 | 328,000 |
| 20-Day Average Volume | 716,795 | 1,736,275 | 6,437,990 | 980,540 | 407,680 |
| Previous Close | 125.69 | 332.80 | 83.05 | 481.26 | 1,146.75 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 132.95 | 329.25 | 79.63 | 480.27 | 1,167.27 |
| 20-Day Raw Stochastic | 19.29% | 69.60% | 90.09% | 34.05% | 26.10% |
| 20-Day Relative Strength | 36.89% | 55.28% | 71.85% | 47.32% | 50.26% |
| Weighted Alpha | +0.78 | +25.51 | +18.22 | +32.08 | +39.19 |
| Today's Opinion | 24% Sell | 88% Buy | 88% Buy | 40% Buy | 80% Buy |
| Previous Opinion | 24% Sell | 88% Buy | 88% Buy | 56% Buy | 80% Buy |
| Last Month's Opinion | 40% Buy | 72% Buy | 40% Buy | 88% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.63% since 09/11/24 | +0.89% since 09/11/24 | +3.64% since 09/11/24 | -0.12% since 09/11/24 | -0.23% since 09/11/24 |
| Low | 120.42 on 09/13/24 | 326.41 on 09/12/24 | 81.57 on 09/13/24 | 468.46 on 09/12/24 | 1,127.20 on 09/12/24 |
| High | 128.08 on 09/18/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 490.15 on 09/16/24 | 1,170.58 on 09/13/24 |
| 1-Month | |||||
| %Chg | -6.33% since 08/16/24 | +3.57% since 08/16/24 | +13.70% since 08/16/24 | -0.67% since 08/16/24 | -3.43% since 08/16/24 |
| Low | 120.42 on 09/13/24 | 319.00 on 09/06/24 | 73.27 on 08/19/24 | 460.69 on 09/11/24 | 1,113.24 on 09/11/24 |
| High | 144.22 on 08/22/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 500.25 on 08/30/24 | 1,211.20 on 08/27/24 |
| 3-Month | |||||
| %Chg | +6.37% since 06/18/24 | +8.80% since 06/18/24 | +32.84% since 06/18/24 | +1.47% since 06/18/24 | +9.59% since 06/18/24 |
| Low | 115.74 on 06/20/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 458.04 on 08/13/24 | 1,011.67 on 07/03/24 |
| High | 173.25 on 06/21/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| 6-Month | |||||
| %Chg | +0.84% since 03/18/24 | +22.89% since 03/18/24 | +14.51% since 03/18/24 | +15.26% since 03/18/24 | +18.64% since 03/18/24 |
| Low | 109.91 on 05/28/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 391.01 on 04/18/24 | 875.22 on 04/26/24 |
| High | 173.25 on 06/21/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 510.64 on 08/01/24 | 1,211.20 on 08/27/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 11,880,722 | 178,525,568 | 103,468,096 | 124,190,592 | 126,355,776 |
| Shares Outstanding, K | 94,524 | 536,435 | 1,245,853 | 258,053 | 110,186 |
| Annual Sales | 1,243,340,000 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 13,117,200,000 |
| Annual Net Income | -535,980,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 3,953,600,000 |
| Last Quarter Sales | 362,930,000 | 8,388,000,000 | 6,954,000,000 | 2,645,600,000 | 3,547,100,000 |
| Last Quarter Net Income | 6,460,000 | 746,000,000 | 1,614,000,000 | -3,593,600,000 | 1,432,300,000 |
| 60-Month Beta | 0.81 | 0.61 | 0.18 | 0.40 | 0.12 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.07 on 08/07/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | -12.83 on 08/01/24 | 11.56 on 08/01/24 |
| Latest Earnings Date | 11/06/24 | 10/29/24 | 11/05/24 | 11/04/24 | 11/07/24 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 270.28 | 18.02 | 17.69 | 0.00 | 30.01 |